Innate Pharma (IPHA) Institutional Ownership → This Apple-like Innovator is Revolutionizing Healthcare (From Wall Street Star) (Ad) Free IPHA Stock Alerts $2.90 +0.19 (+7.01%) (As of 12:14 PM ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Innate Pharma (NASDAQ:IPHA)CurrentInstitutional OwnershipPercentage0.16%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$438.08KNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$925.42K Get IPHA Insider Trade Alerts Want to know when executives and insiders are buying or selling Innate Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data IPHA Institutional Buying and Selling by Quarter Ad Stansberry ResearchEverybody laughed when he recommended Netflix"This Could be Worth Even More than A.I." Whitney Tilson's nailed many of the most famous stocks of the last 25 years – including Netflix, Amazon, and Apple. Now he's pounding the table on a new technology rolling out across America, which early estimates say could create more wealth than A.I., the personal computer, and the smartphone combined. Click here to see how it could become the No. 1 investment of the next decade. Innate Pharma Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/13/2024 Optiver Holding B.V.22,705$64K0.0%-88.1%0.028% 1/5/2024 Exchange Traded Concepts LLC46,888$131K0.0%+34.0%0.058% 11/13/2023 Optiver Holding B.V.190,219$481K0.0%+132.6%0.236% 10/18/2023 Exchange Traded Concepts LLC34,998$89K0.0%-17.5%0.043% 8/10/2023 Optiver Holding B.V.81,796$257K0.0%-63.5%0.102% 7/20/2023 Exchange Traded Concepts LLC42,431$133K0.0%N/A0.053% 5/11/2023 Optiver Holding B.V.224,097$636K0.0%+112.3%0.279% 2/14/2023Susquehanna International Group LLP13,315$50K0.0%N/A0.017% 2/10/2023 Optiver Holding B.V.105,534$394K0.0%-43.1%0.132% 8/10/2022 Optiver Holding B.V.181,944$491K0.0%+366.8%0.228% 2/9/2022 Alps Advisors Inc.93,718$429K0.0%N/A0.118% 12/1/2021 Balyasny Asset Management LLC187,484$1.16M0.0%N/A0.236% 11/16/2021 Two Sigma Securities LLC17,119$106K0.0%N/A0.022% 11/15/2021 Pura Vida Investments LLC82,509$509K0.0%N/A0.104% 11/15/2021 Balyasny Asset Management LLC187,484$1.16M0.0%N/A0.236% 11/12/2021 Affinity Asset Advisors LLC125,000$771K0.2%N/A0.158% 5/21/2021 Citadel Advisors LLC25,250$109K0.0%N/A0.032% 5/20/2021 Optiver Holding B.V.30,284$131K0.0%N/A0.038% 5/18/2021 Millennium Management LLC49,734$214K0.0%-9.1%0.063% 5/18/2021 Citadel Advisors LLC25,250$109K0.0%N/A0.032% 5/14/2021 Optiver Holding B.V.55,588$240K0.0%N/A0.070% 5/14/2020 Wellington Management Group LLP1,334,110$8.91M0.0%-1.5%1.743% (Data available from 1/1/2016 forward) IPHA Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of IPHA shares? During the previous two years, the following institutional investors and hedge funds held shares of Innate Pharma shares: Exchange Traded Concepts LLC ($131K), and Optiver Holding B.V. ($64K), Susquehanna International Group LLP ($50K).Learn more on IPHA's institutional investors. What percentage of Innate Pharma stock is owned by institutional investors? 0.16% of Innate Pharma stock is owned by institutional investors. Learn more on IPHA's institutional investor holdings. Which institutional investors have been buying Innate Pharma stock? The following institutional investors have purchased Innate Pharma stock in the last 24 months: Optiver Holding B.V. ($369.96K), Exchange Traded Concepts LLC ($54.32K), and Susquehanna International Group LLP ($13.32K). How much institutional buying is happening at Innate Pharma? Institutional investors have bought a total of 437,592 shares in the last 24 months. This purchase volume represents approximately $1.21M in transactions. Which Innate Pharma major shareholders have been selling company stock? The following institutional investors have sold Innate Pharma stock in the last 24 months: Optiver Holding B.V. ($389.59K), and Exchange Traded Concepts LLC ($7.43K). How much institutional selling is happening at Innate Pharma? Institutional investors have sold a total of 397,024 shares in the last 24 months. This volume of shares sold represents approximately $1.22M in transactions. Related Companies: ADVM Major Shareholders KOD Major Shareholders IPSC Major Shareholders INMB Major Shareholders ABOS Major Shareholders ZURA Major Shareholders OPT Major Shareholders CMPX Major Shareholders CGEN Major Shareholders ELEV Major Shareholders This page (NASDAQ:IPHA) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersElon to Transform U.S. Economy? Porter & CompanyRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldDoes this make you sick?Allegiance GoldThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersThis Apple-like Innovator is Revolutionizing HealthcareWall Street Star**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge Alerts Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Innate Pharma S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.